Cargando…
Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited ge...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483566/ https://www.ncbi.nlm.nih.gov/pubmed/32341498 http://dx.doi.org/10.1038/s41379-020-0546-8 |
_version_ | 1783580942171897856 |
---|---|
author | Ordulu, Zehra Chai, Hongyan Peng, Gang McDonald, Anna G De Nictolis, Michele Garcia-Fernandez, Eugenia Hardisson, David Prat, Jaime Li, Peining Hui, Pei Oliva, Esther Buza, Natalia |
author_facet | Ordulu, Zehra Chai, Hongyan Peng, Gang McDonald, Anna G De Nictolis, Michele Garcia-Fernandez, Eugenia Hardisson, David Prat, Jaime Li, Peining Hui, Pei Oliva, Esther Buza, Natalia |
author_sort | Ordulu, Zehra |
collection | PubMed |
description | Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited genetic data. In this study, we assessed the clinical and morphological characteristics of 28 IVL and their correlation with molecular features and protein expression, using array comparative genomic hybridization (aCGH) and Cyclin D1, p16, phosphorylated-Rb, SMARCB1, SOX10, CAIX, SDHB and FH immunohistochemistry. The most common morphologies were cellular (n=15), usual (n=11) and vascular (n=5; including 3 cellular IVL showing both vascular and cellular features). Among the immunohistochemical findings, the most striking was that all IVL showed differential expression of either p16 or Cyclin D1 in comparison to surrounding non-neoplastic tissue. Cytoplasmic phosphorylated-Rb was present in all but one IVL with hyalinization. SMARCB1, FH and SDHB were retained; S0X10 and CAIX were not expressed. The most common genetic alterations involved 1p (39%), 22q (36%), 2q (29%), 1q (25%), 13q (21%) and 14q (21%). Hierarchical clustering analysis of recurrent aberrations revealed 3 molecular groups: Group 1 (29%) and 2 (18%) with associated del(22q) and group 3 (18%) with del(10q). The remaining IVL had non-specific or no alterations by aCGH. Genomic index scores were calculated for all cases and showed no significant difference between the 14 IVL associated with aggressive clinical behavior (extrauterine extension or recurrence) and those without (median scores 5.15 vs 3.5). Among the 5 IVL associated with recurrence, 4 had a vascular morphology and 3 had alterations of 8q. Recurrent chromosome alterations detected herein overlap with those observed in the spectrum of uterine smooth muscle tumors and involve genes implicated in mesenchymal tumors at different sites with distinct morphological features. |
format | Online Article Text |
id | pubmed-7483566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-74835662020-10-27 Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis Ordulu, Zehra Chai, Hongyan Peng, Gang McDonald, Anna G De Nictolis, Michele Garcia-Fernandez, Eugenia Hardisson, David Prat, Jaime Li, Peining Hui, Pei Oliva, Esther Buza, Natalia Mod Pathol Article Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited genetic data. In this study, we assessed the clinical and morphological characteristics of 28 IVL and their correlation with molecular features and protein expression, using array comparative genomic hybridization (aCGH) and Cyclin D1, p16, phosphorylated-Rb, SMARCB1, SOX10, CAIX, SDHB and FH immunohistochemistry. The most common morphologies were cellular (n=15), usual (n=11) and vascular (n=5; including 3 cellular IVL showing both vascular and cellular features). Among the immunohistochemical findings, the most striking was that all IVL showed differential expression of either p16 or Cyclin D1 in comparison to surrounding non-neoplastic tissue. Cytoplasmic phosphorylated-Rb was present in all but one IVL with hyalinization. SMARCB1, FH and SDHB were retained; S0X10 and CAIX were not expressed. The most common genetic alterations involved 1p (39%), 22q (36%), 2q (29%), 1q (25%), 13q (21%) and 14q (21%). Hierarchical clustering analysis of recurrent aberrations revealed 3 molecular groups: Group 1 (29%) and 2 (18%) with associated del(22q) and group 3 (18%) with del(10q). The remaining IVL had non-specific or no alterations by aCGH. Genomic index scores were calculated for all cases and showed no significant difference between the 14 IVL associated with aggressive clinical behavior (extrauterine extension or recurrence) and those without (median scores 5.15 vs 3.5). Among the 5 IVL associated with recurrence, 4 had a vascular morphology and 3 had alterations of 8q. Recurrent chromosome alterations detected herein overlap with those observed in the spectrum of uterine smooth muscle tumors and involve genes implicated in mesenchymal tumors at different sites with distinct morphological features. 2020-04-27 2020-09 /pmc/articles/PMC7483566/ /pubmed/32341498 http://dx.doi.org/10.1038/s41379-020-0546-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Ordulu, Zehra Chai, Hongyan Peng, Gang McDonald, Anna G De Nictolis, Michele Garcia-Fernandez, Eugenia Hardisson, David Prat, Jaime Li, Peining Hui, Pei Oliva, Esther Buza, Natalia Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis |
title | Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis |
title_full | Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis |
title_fullStr | Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis |
title_full_unstemmed | Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis |
title_short | Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis |
title_sort | molecular and clinicopathologic characterization of intravenous leiomyomatosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483566/ https://www.ncbi.nlm.nih.gov/pubmed/32341498 http://dx.doi.org/10.1038/s41379-020-0546-8 |
work_keys_str_mv | AT orduluzehra molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT chaihongyan molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT penggang molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT mcdonaldannag molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT denictolismichele molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT garciafernandezeugenia molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT hardissondavid molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT pratjaime molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT lipeining molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT huipei molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT olivaesther molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis AT buzanatalia molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis |